Bigelow Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $216K | Sell |
8,978
-198
| -2% | -$5.18K | 0.08% | 155 |
|
|
2026
Q1 | $258K | Sell |
9,176
-430
| -4% | -$11.4K | 0.1% | 137 |
|
|
2025
Q4 | $239K | Sell |
9,606
-3,617
| -27% | -$91.2K | 0.09% | 141 |
|
|
2025
Q3 | $337K | Sell |
13,223
-1,670
| -11% | -$41.2K | 0.14% | 131 |
|
|
2025
Q2 | $361K | Sell |
14,893
-1,219
| -8% | -$28.4K | 0.16% | 124 |
|
|
2025
Q1 | $408K | Sell |
16,112
-805
| -5% | -$21.1K | 0.19% | 118 |
|
|
2024
Q4 | $449K | Sell |
16,917
-13,305
| -44% | -$361K | 0.21% | 114 |
|
|
2024
Q3 | $875K | Sell |
30,222
-555
| -2% | -$16.2K | 0.39% | 77 |
|
|
2024
Q2 | $861K | Sell |
30,777
-600
| -2% | -$16.5K | 0.41% | 71 |
|
|
2024
Q1 | $871K | Buy |
31,377
+6,965
| +29% | +$193K | 0.43% | 72 |
|
|
2023
Q4 | $703K | Sell |
24,412
-2,516
| -9% | -$76.1K | 0.38% | 75 |
|
|
2023
Q3 | $893K | Sell |
26,928
-439
| -2% | -$15.5K | 0.51% | 61 |
|
|
2023
Q2 | $1M | Buy |
27,367
+324
| +1% | +$12.6K | 0.55% | 56 |
|
|
2023
Q1 | $1.1M | Sell |
27,043
-1,330
| -5% | -$57.4K | 0.64% | 47 |
|
|
2022
Q4 | $1.45M | Sell |
28,373
-450
| -2% | -$21.6K | 0.84% | 32 |
|
|
2022
Q3 | $1.26M | Buy |
28,823
+892
| +3% | +$43.3K | 0.75% | 42 |
|
|
2022
Q2 | $1.46M | Buy |
27,931
+2,467
| +10% | +$126K | 0.8% | 37 |
|
|
2022
Q1 | $1.32M | Buy |
25,464
+489
| +2% | +$25.4K | 0.62% | 46 |
|
|
2021
Q4 | $1.48M | Sell |
24,975
-794
| -3% | -$39.3K | 0.67% | 40 |
|
|
2021
Q3 | $1.11M | Sell |
25,769
-1,948
| -7% | -$86.3K | 0.55% | 52 |
|
|
2021
Q2 | $1.08M | Hold |
27,717
| – | – | 0.53% | 52 |
|
|
2021
Q1 | $1M | Sell |
27,717
-280
| -1% | -$9.94K | 0.51% | 54 |
|
|
2020
Q4 | $1.03M | Sell |
27,997
-2,323
| -8% | -$85.2K | 0.55% | 49 |
|
|
2020
Q3 | $1.06M | Sell |
30,320
-187
| -0.6% | -$6.56K | 0.62% | 43 |
|
|
2020
Q2 | $946K | Buy |
30,507
+1,665
| +6% | +$56.6K | 0.61% | 44 |
|
|
2020
Q1 | $893K | Buy |
28,842
+1,679
| +6% | +$57.2K | 0.67% | 40 |
|
|
2019
Q4 | $1.01M | Sell |
27,163
-126
| -0.5% | -$4.49K | 0.59% | 43 |
|
|
2019
Q3 | $930K | Sell |
27,289
-675
| -2% | -$24.5K | 0.59% | 47 |
|
|
2019
Q2 | $1.15M | Sell |
27,964
-1,679
| -6% | -$66.7K | 0.77% | 34 |
|
|
2019
Q1 | $1.19M | Sell |
29,643
-5,653
| -16% | -$226K | 0.83% | 32 |
|
|
2018
Q4 | $1.46M | Sell |
35,296
-106
| -0.3% | -$4.4K | 1.09% | 24 |
|
|
2018
Q3 | $1.48M | Sell |
35,402
-1,430
| -4% | -$55K | 1% | 24 |
|
|
2018
Q2 | $1.27M | Sell |
36,832
-1,018
| -3% | -$34.8K | 0.87% | 31 |
|
|
2018
Q1 | $1.27M | Buy |
37,850
+30,715
| +430% | +$1.06M | 0.87% | 29 |
|
|
2017
Q4 | $245K | Buy |
+7,135
| New | +$243K | 0.24% | 93 |
|
Other funds holding PFE
Bigelow Investment Advisors's PFE Position: Q2 2026 in Review
Bigelow Investment Advisors reduced its Pfizer (PFE) stake by 2.2% in Q2 2026, selling an estimated $5.18K and leaving 8,978 shares worth $216K. The position accounts for 0.08% of the portfolio, ranked #155.
Bigelow Investment Advisors first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.48M in Q3 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bigelow Investment Advisors held 8,978 shares of Pfizer worth $216K as of Q2 2026.
- Bigelow Investment Advisors sold 198 Pfizer shares in Q2 2026, an estimated $5.18K.
- Pfizer made up 0.08% of Bigelow Investment Advisors's portfolio in Q2 2026, its #155 holding.
- Bigelow Investment Advisors first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Bigelow Investment Advisors's Pfizer position peaked at $1.48M in Q3 2018.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bigelow Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.